Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 1, 1999, Pages 69-72

  Newton, Paul ^a,b   Keeratithakul, Duangsuda ^c   Teja Isavadharm, Paktiya ^c   Pukrittayakamee, Sasithon ^a   Kyle, Dennis ^c   White, Nicholas ^a,b,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

3 Hydroxyquinine; Chemotherapy; Malaria; Pharmacokinetics; Plasmodium falciparum; Quinine; Renal failure; Thailand

Indexed keywords

HYDROQUININE; QUININE;

ACUTE KIDNEY FAILURE; ADULT; ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOXICITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MALE; NONHUMAN; PERITONEAL DIALYSIS; PLASMODIUM FALCIPARUM; THAILAND;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032978640     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90184-0     Document Type: Article

References (10)

1. Edstein, M. D., Prasitthipayong, A., Sabchareon, A., Chongsuphajaisiddhi, T. & Webster, H. K. (1990). Simultaneous measurement of quinine and quinidine in human plasma, whole blood, and erythrocytes by high-performance liquid chromatography with fluorescence detection. Therapeutic Drug Monitoring, 12, 493-500.
2. Krishna, S. & White, N. J. (1996). Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clinical Pharmacokinetics, 30, 263-299.
3. Nontprasert, A., Pukrittayakamee, S., Kyle, D. E., Vanijanonta, S. & White, N. J. (1996). Antimalarial activity and interactions between quinine, dihydroquinine and 3-hydroxyquinine against Plasmodium falciparum in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 553-555.
4. Pukrittayakamee, S., Looareesuwan, S., Keeratithakul, D., Davis, T. M., Teja-Isavadharm, B., Nagachinta, B., Weber, A., Smith, A., Kyle, D. & White, N. J. (1997). A study of the factors affecting the metabolic clearance of quinine in malaria. European Journal of Clinical Pharmacology, 52, 487-493.
5. Vozeh, S., Bindschedler, M., Ha, H. R., Kaufmann, G., Guentert, T. W. & Follath, F. (1987). Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons. American Journal of Cardiology, 59, 681-684.
6. White, N. J. (1992). Antimalarial pharmacokinetics and treatment regimens. British Journal of Clinical Pharmacology, 34, 1-10.
7. White, N. J., Looareesuwan, S., Warrell, D. A., Warrell, M. J., Bunnag, D. & Harinasuta, T. (1982). Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. American Journal of Medicine, 73, 564-572.
8. White, N. J., Looareesuwan, S., Warrell, D. A., Warrell, M. J., Chanthavanich, P., Bunnag, D. & Harinasuta, T. (1983). Quinine loading dose in cerebral malaria. American Journal of Tropical Medicine and Hygiene, 32, 1-5.
9. WHO (1990). Severe and complicated malaria, 2nd edition. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.
10. Zhao, X. J., Yokoyama, H., Chiba, K., Wanwimolruk, S. & Ishizaki, T. (1996). Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. Journal of Pharmacology and Experimental Therapeutics, 279, 1327-1334.